RelatedTable Application Registration Registration Products Title Nation Date Application Number Date Number -------- ---------------------------------- ------ ----------- --------------------- ------------ ------------- KOREA 2000.5.2 2000-23505 2001.4.13 0294317 USA 2000.6.2 09-585361 2004.3.2 6698502 JAPAN 2000.6.1 2000-165037 2001.6.21 3202014 Micro Cooling Device Taiwan 2002.6.3 9110906 2002.12.3 161006 PCT number : WO00/075764 CHINA 2002.1.2 810704.1 2004.12.29 ZL 00810704.1 RUSSIA 2001.12.4 2001132727 pending pending INDIA 2001.12.3 IN/PCT/2001/01105/DEL pending pending EUROPE 2001.12.3 937337.4 pending pending MCS Thin Film Cooling System KOREA 2001.8.29 10-2001-0052584 2003.12.29 0414860 Cooling device of hybrid type KOREA 2003.1.24 10-2003-0004932 pending pending PCT 2003.10.28 PCT/KR2003/002282 pending pending Cooling device of thin plate type KOREA 2003.5.31 10-2003-0035078 pending pending for preventing dry out PCT 2003.10.28 PCT/KR2003/002281 pending pending Planar type heat transferring KOREA 2004.11.10 10-2004-0091617 pending pending device and manufacturing method thereof Heat transfer device and KOREA 2005.1.6 10-2005-0001028 pending pending manufacturing method thereof using hydrophilic wickContents

~~NUMBER~~UNITED OFSTATES SECURITIES ~~SHARES~~AND ~~PERCENTAGE~~EXCHANGE OF SHARES BENEFICIALLY BENEFICIALLY OWNED(1) OWNED (1) ---------------- -------------------- Hakan Wretsell 1,713,678 2.62% Michael Karpheden 1,207,715 1.85% Dr. Lee 16,404,234 25.10% All officers and directors as a group (3 persons) 19,325,627 29.57%COMMISSION

~~NAME AGE POSITION ---- --- -------- Hakan Wretsell 45 Chief Executive Officer~~WASHINGTON, ~~President and Director Michael Karpheden 43 Chief Operating Officer, Chief Financial Officer and Secretary Dr~~D. ~~Lee 41 Chief Technology Officer and Director Alan B~~C. ~~Miller 51 Director~~20549

~~MR.~~FORM ~~WRETSELL MR. KARPHEDEN DR. LEE~~ 8------------ ------------- ------- Annual Salary $262,500 $220,500 $262,500 Closing Bonus(1) $40,000 and 45,455 shares of $33,600 and 38,182 shares of $40,000 and 45,455 shares of common stock common stock common stock 2005 Bonus(2) Up to 100% of base salary Up to 60% of base salary Up to 100% of base salary ($262,500) ($132,300) ($262,500) 2006 Bonus(2) Up to 200% of base salary Up to 120% of base salary Up to 200% of base salary ($525,000) ($264,600) ($525,000) Stock Grants(3) 1,633,897 shares of common 1,143,728 shares of common stock 980,338 shares of common stock stock Stock Options(3) 326,779 shares of common stock 326,779 shares of common stock 326,779 shares of common stockK

~~GROSS~~CURRENT ~~PERCENTAGE~~REPORT ~~CASH~~PURSUANT OFTO ~~NET~~SECTION ~~PROCEEDS~~13 ~~PROCEEDS~~OR ~~-------- ---------- Proceeds 12.48 -- ===== Placement Agent Cash Fee~~ 15(~~10%~~d) ~~1.248~~OF THE ~~10.0%~~SECURITIES ~~Closing~~EXCHANGE ~~Costs~~ACT ~~0.98~~OF 7.85% Potential buy-out of minority shares 2.0 16.03% Satisfaction of convertible bonds/liabilities 0.7 5.61% Advance Payment 0.5 4.01% Capital expenditures 1.2 9.62% Net working capital 1.95 15.63% Public company costs 0.8 6.41% Operating expenses 3.1 24.84% 12.48 100% =====1934

Date of report (Date of earliest event reported): August 2, 2005

iCURIE, INC.

(Exact Name of Registrant as Specified in its Charter)


Nevada (State or other jurisdiction of incorporation or organization)		333-64840 (Commission File Number)		91-2015441 (I.R.S. Employer Identification No.)

Espirito Santo Plaza
1395 Brickell Avenue, Suite 800
Miami, Florida 33131
(Address of principal executive offices and Zip Code)

Registrant’s telephone number, including area code: (305) 529-6290

Not applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

TABLE OF CONTENTS


	Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Directors.
	Item 7.01 Regulation FD Disclosure.
	Item 9.01 Financial Statements and Exhibits
SIGNATURES
EXHIBIT INDEX
Press Release

Item 5.02 Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Directors.

On August 2, 2005, the board of directors of iCurie, Inc. (the “Company”) increased the size of the board from three to six and appointed David H. Clarke, Gregory J. Osborn and Peter Rugg as directors of the Company. Certain biographical data regarding Messrs. Clarke and Rugg was included in the Company’s current report on Form 8-K dated July 8, 2005 (the “July 8 8-K”). Mr. Osborn is an affiliate of Indigo Securities LLC, which acted as placement agent to, and received fees from, the Company as reported in the July 8 8-K. Prior to launching IndiGo Ventures (an affiliate of Indigo Securities LLC), Mr. Osborn founded Seed Capital, which provided new business development, strategic partnering and fundraising services for cutting-edge Internet companies, and served as head of business development for FreeRide.com. His background in finance and investment began on Wall Street, working at the headquarters offices of L.F. Rothschild & Co. and Drexel, Burnham, Lambert as an Account Executive and as Vice President at Smith Barney Harris & Upham, First Vice President at Paine Webber, and Senior Vice President of Axiom Capital Management. Mr. Osborn serves on the Board of Directors of Powerhouse Technologies Group, Inc., Children of Bellevue and ideavillage.com. Mr. Osborn also serves as corporate advisor to Advance Nanotech Inc.

The appointment of Messrs. Clarke and Rugg as directors was effectuated pursuant to action by written consent of the stockholders of the Company’s Series A preferred stock, which stockholders are entitled to elect two directors of the Company pursuant to the terms of the Series A preferred stock.

Item 7.01 Regulation FD Disclosure.

The press release attached hereto as Exhibit 99.1 is hereby incorporated into this Item 7.01 solely for purposes of compliance with Regulation FD.

Item 9.01 Financial Statements and Exhibits

(c) Exhibits


	Exhibit No.		Description
	99.1		Press release dated August 8, 2005

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


Date: August 5, 2005	iCURIE, INC.
	By:	/s/ Michael Karpheden
		Michael Karpheden
		Chief Financial Officer

EXHIBIT INDEX


Exhibit No.		Description
99.1		Press release dated August 8, 2005

Table of Contents

Table of Contents

Table of Contents

Filing Compare · Celsia Technologies, Inc.